Quoin Pharmaceuticals (QNRX) Current Assets (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Current Assets of $15.3 million for Q1 2026, down 23.35% sequentially from $20.0 million in Q4 2025, and up 22.71% YoY from $12.5 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Current Assets (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Current Assets for 10 years, with the latest figure at $15.3 million in Q1 2026.
- Quarterly Current Assets rose 22.71% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 22.71% YoY) and the FY2025 annual result came in at $20.0 million, up 34.04% from the prior year.
- Current Assets retreated to $15.3 million in Q1 2026 per QNRX's latest filing, from $20.0 million in the prior quarter.
- Over five years, Current Assets peaked at $20.0 million in Q4 2025 and troughed at $3.5 million in Q2 2022.
- A 5-year average of $13.0 million and a median of $13.8 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets surged 345.95% in 2023, then plunged 42.7% in 2025.
- Over 5 years, Current Assets stood at $13.4 million in 2022, then declined by 15.59% to $11.3 million in 2023, then jumped by 32.25% to $14.9 million in 2024, then soared by 34.04% to $20.0 million in 2025, then retreated by 23.35% to $15.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $15.3 million, $20.0 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.33 Mn |
| Dec 31, 2025 | 20.01 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | 8.48 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 14.93 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 13.22 Mn |
| Mar 31, 2024 | 15.26 Mn |
| Dec 31, 2023 | 11.29 Mn |
| Sep 30, 2023 | 14.14 Mn |
| Jun 30, 2023 | 15.67 Mn |
| Mar 31, 2023 | 17.39 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Sep 30, 2022 | 15.66 Mn |
| Jun 30, 2022 | 3.51 Mn |
| Dec 31, 2021 | 8.20 Mn |
| Dec 31, 2020 | 465,170.00 |
| Jun 30, 2020 | 7.28 Mn |
| Jun 30, 2019 | 7.83 Mn |